Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-04-13
1998-08-18
MacMillan, Keith
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514885, 514886, A61K 3152
Patent
active
057958971
ABSTRACT:
There is disclosed a pharmaceutical composition comprising 1-(5-oxohexyl)-3-methylxanthine in admixture with a pharmaceutically acceptable excipient, wherein the pharmaceutical composition is useful for treating an immune disorder. There is also disclosed a method to modulate the response of a target cell to a stimulus, which method comprises contacting said cell with an amount of 1-(5-oxohexyl)-3-methylxanthine or a pharmaceutical composition thereof, wherein said amount effects a diminution in elevated levels of unsaturated, non-arachidonate phosphatidic acid (PA) and diacylglycerol (DAG) derived from said PA in said cells wherein said elevated levels are stimulated by an agent capable of elevating levels of said PA and said DAG, said diminution being equal to or greater than the diminution effected by treating said cells with pentoxifylline (PTX) at a concentration of 0.5 mmol, thereby modulating the response of said target cell.
REFERENCES:
patent: 3422107 (1969-01-01), Mohler et al.
patent: 4515795 (1985-05-01), Hinze et al.
patent: 4576947 (1986-03-01), Hinze et al.
patent: 4636507 (1987-01-01), Kreutzer et al.
patent: 4965271 (1990-10-01), Mandell et al.
patent: 4975432 (1990-12-01), Weithmann
patent: 5096906 (1992-03-01), Mandell et al.
patent: 5118500 (1992-06-01), Hanel et al.
patent: 5288721 (1994-02-01), Klein et al.
patent: 5652243 (1997-07-01), Bianco et al.
patent: B13373737 (1987-03-01), Mohler et al.
Davis et al., Applied Environment. Microbiol. 48:327, 1984.
Bianco et al., Blood 78:1205, 1991.
Singer et al., "Effect of Methylxanthine Derivatives on T cell Activation" Bone Marrow Transplantation 10:19, 1992.
Chemical Abstracts An 88-127584 (Dethlefsen et al., May 11, 1988).
J.Pharm. Pharmacol; vol. 44 (11), Issued Nov. 1992, Miyamoto et al, "Selective Bronchodilators from 1-(5'-Oxohexyl)xanthines", pp. 888-892.
Chemical Abstracts 1988: 105950, Wijnandy et al., 1988.
Chemical Abstracts 88-127584, issued 1989, corresponding to DE 3637241 to Dethlefson et al., "Pharmaceutical Compsns. Contg. Nifedipine -and complexing Substance to increase water-solubility", (Abstract only).
Medline Abstract # 88256298 Sullivan et al, "Inhibition of the Inflammatory Action of interleukin-1 and Tumor Necrosis Factor on neutrophil Function by Pentoxifylline", Infect Immun, 56(7)1722-9, Jul. 1988.
Cell Therapeutics Inc.
Faciszewski Stephen
MacMillan Keith
Shumate Cynthia L.
LandOfFree
Oxohexyl methylxanthine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxohexyl methylxanthine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxohexyl methylxanthine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1115028